Windlas Biotech Limited has informed the Exchange about submission of Letter of Offer for Buyback
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Windlas Biotech Limited has announced a buyback of up to 4,70,000 fully paid-up equity shares (2.23% of total paid-up capital) at a price of INR 1,000 per share in cash. The total buyback size is INR 47 crore (9.80% of paid-up capital and free reserves, within the statutory 10% limit). The record date was April 24, 2026, and the tendering window runs from April 30, 2026 to May 7, 2026. Shareholders can tender shares on a proportionate basis with an entitlement ratio of 1 share for every 18 shares held. Small shareholders holding shares worth up to INR 2 lakh are in a reserved category.
The buyback offers shareholders a chance to exit at INR 1,000 per share, providing an exit opportunity and potential return of capital. The significant premium over face value indicates management confidence in the company's intrinsic value, which could be positive for stock sentiment.